The Peter Attia Drive


Show info


Episodes

454

Total time

695 hours and 48 minutes

Oldest episode

June 19, 2018

Most recent

September 14, 2026

Avg. length

1 hour and 32 minutes

Avg. words/min

180

Avg. word count

16,854

Avg. sentences

1,028.0

Avg. harmful content per episode

Misogyny

9.7

sentences flagged

Toxicity

9.5

sentences flagged

Hate speech

9.8

sentences flagged


Notable people

Names network graph
Showing episodes featuring GLP-1 clear filter
Hosts: Peter Attia (2)
Frequent guests: Nick Stenson (7) Bob Kaplan (6) Quarterly Podcast Summary (5) Layne Norton (3) Peter Attia (3) Rhonda Patrick (3) Andy Galpin (2) Bill Perkins (2) David Allison (2) Derek (2) Marty Makary (2) Michael Easter (2) Olav Aleksander Bu (2) Peter Hotez (2) Ric Elias (2) Sebastian Junger (2) Stuart McGill (2) Ted Schaeffer (2) Tom Dayspring (2) Walter Green (2)
Frequently mentioned: Peter Attia (404) Drive (85) Austin (44) Bob Kaplan (44) peter atia (38) VO2 max (35) Tim Ferriss (32) Tom Dayspring (27) Matthew Walker (26) David Sabatini (24) Matt Caberlin (24) GLP-1 (22) Pfizer (22) Sam Harris (22) Formula One (20) Jill (20) David Sinclair (19) Einstein (19) Hopkins (19) McKinsey (19) Richard Isaacson (19) Steve Rosenberg (19) ApoE (18) Lance Armstrong (18) Nick (18)
Hosts, guests, and mentioned names are extracted automatically with spaCy (en_core_web_sm) and reconciled against Wikidata.

Episodes

SEP
14
2026
#407 ‒ Preventing cardiovascular and Alzheimer's disease： lowering LDL early, APOE4, and promising new therapies ｜ Michael Davidson, M.D.
Misogyny: 5 Toxicity: 5 Hate: 13 1 hour and 59 minutes
APR
13
2026
#387 - AMA #83： Peptides—evaluating the science, safety, and hype in a rapidly growing field
21 minutes
JAN
5
2026
#378 ‒ Women's health and performance： how training, nutrition, and hormones interact across life stages ｜ Abbie Smith-Ryan, Ph.D.
Misogyny: 120 Hate: 36 2 hours and 11 minutes
DEC
8
2025
#375 - Ketogenic diet, ketosis & hyperbaric oxygen： metabolic therapies for weight loss, cognition, Alzheimer's & more ｜ Dom D'Agostino, Ph.D.
Misogyny: 3 Toxicity: 4 Hate: 5 2 hours and 8 minutes
OCT
27
2025
#370 - AMA #76： Peter evaluates longevity drugs, aspirin for CVD, and strategies to improve muscle mass — proven, promising, fuzzy, noise, or nonsense？
Misogyny: 1 Toxicity: 13 Hate: 2 17 minutes
OCT
20
2025
#369 ‒ Rethinking protein needs for performance, muscle preservation, and longevity, and the mental and physical benefits of creatine supplementation and sauna use ｜ Rhonda Patrick, Ph.D.
Misogyny: 11 Hate: 5 1 hour and 49 minutes
OCT
6
2025
#367 - Tylenol, pregnancy, and autism： What recent studies show and how to interpret the data
Misogyny: 11 Toxicity: 3 Hate: 14 1 hour and 27 minutes
AUG
4
2025
#359 ‒ How metabolic and immune system dysfunction drive the aging process, the role of NAD, promising interventions, aging clocks, and more ｜ Eric Verdin, M.D.
Misogyny: 2 Toxicity: 6 Hate: 6 2 hours and 11 minutes
JUL
21
2025
#357 ‒ A new era of longevity science： models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions ｜ Brian Kennedy, Ph.D.
Misogyny: 8 Toxicity: 2 Hate: 8 1 hour and 56 minutes
JUN
9
2025
#352 ‒ Female fertility： optimizing reproductive health, diagnosing and treating infertility and PCOS, and understanding the IVF process ｜ Paula Amato, M.D.
Misogyny: 157 Toxicity: 19 Hate: 75 2 hours and 23 minutes
FEB
24
2025
#337 - Insulin resistance masterclass： The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment ｜ Ralph DeFronzo, M.D.
Misogyny: 4 Hate: 13 2 hours and 26 minutes
NOV
4
2024
#324 ‒ Metabolism, energy balance, and aging： How diet, calorie restriction, and macronutrients influence longevity and metabolic health ｜ Eric Ravussin, Ph.D.
Misogyny: 4 Toxicity: 1 Hate: 11 2 hours and 9 minutes
OCT
14
2024
#321 – Dopamine and addiction： navigating pleasure, pain, and the path to recovery ｜ Anna Lembke, M.D.
Misogyny: 12 Toxicity: 10 Hate: 9 2 hours and 22 minutes
OCT
7
2024
#320 – AMA 64： New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
Misogyny: 1 20 minutes
AUG
19
2024
#314 ‒ Rethinking nutrition science： the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards ｜ David Allison, Ph.D.
Misogyny: 3 Toxicity: 5 Hate: 4 1 hour and 58 minutes
MAY
20
2024
#302 - Confronting a metabolic epidemic： understanding liver health and how to prevent, diagnose, and manage liver disease ｜ Julia Wattacheril, M.D., M.P.H.
Misogyny: 11 Hate: 9 2 hours and 24 minutes
DEC
18
2023
#283 ‒ Gut health & the microbiome： improving and maintaining the microbiome, probiotics, prebiotics, innovative treatments, and more ｜ Colleen Cutcliffe, Ph.D.
Misogyny: 13 Toxicity: 15 Hate: 14 2 hours and 32 minutes
SEP
11
2023
#270 ‒ Journal club with Andrew Huberman： metformin as a geroprotective drug, the power of belief, and how to read scientific papers
Toxicity: 7 Hate: 14 2 hours and 17 minutes
NOV
21
2022
A masterclass on insulin resistance—mechanisms and implications ｜ Gerald Shulman, M.D., Ph.D. (#140 rebroadcast)
Misogyny: 1 Toxicity: 1 Hate: 2 2 hours and 6 minutes
JUN
27
2022
#212 - The neuroscience of obesity ｜ Stephan Guyenet, Ph.D.
Misogyny: 13 Toxicity: 5 Hate: 8 2 hours and 25 minutes